Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
26.8 EUR | 0.00% |
|
+1.52% | +3.08% |
02/07 | Tranche Update on Nomura Research Institute, Ltd.'s Equity Buyback Plan announced on April 25, 2024. | CI |
25/04 | Nomura Research Institute’s Attributable Profit Up 4.8% in Fiscal 2024 | MT |
Strengths
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- With an expected P/E ratio at 30.15 and 27.12 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's enterprise value to sales, at 3.6 times its current sales, is high.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The company is highly valued given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: IT Services & Consulting
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.08% | 16.72B | - | ||
-12.87% | 192B | A- | ||
+5.64% | 174B | B+ | ||
+7.45% | 161B | B- | ||
+1.69% | 96.97B | A- | ||
+51.64% | 94.22B | C- | ||
+16.05% | 85.18B | A- | ||
+7.59% | 81.86B | A | ||
+3.65% | 49.37B | A- | ||
-28.21% | 47.84B | C |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 4307 Stock
- NR7 Stock
- Ratings Nomura Research Institute, Ltd.